Skip to content
Catalyst

PapersPMID:36277954

Does Moringa oleifera Lam. leaves supplementation have an impact on the weight and bone mass index of people living with HIV that are on antiretroviral therapy? A double-blind randomized control trial.

Journal of public health in Africa2022The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidenceno difference foundBody mass index
  2. Finding, limited evidenceno difference foundBody mass
Study, every finding
RCT · 6 months
Dose studied, every finding
15 g/day leaf powder sachet, divided into three 5 g portions added to food before eating, 6 months
Population, every finding
adults living with HIV in Kano, Nigeria, on tenofovir + lamivudine + efavirenz antiretroviral therapy for at least three months

No finding here moved its endpoint.

Study record

Design
randomised controlled trial
Species
human
Population
Adults living with HIV on tenofovir + lamivudine + efavirenz ART, S.S Wali Virology Centre, Aminu Kano Teaching Hospital, Kano, Nigeria; Moringa oleifera leaf powder versus chlorophyll-coloured corn starch placebo
Participants
200
Comparator
placebo
Duration
183 days
Endpoints measured
14